[Index] [Search] [Download] [Related Items] [Help]
This is a Bill, not an Act. For current law, see the Acts databases.
Serial 55
Misuse of
Drugs Amendment Bill 2013
Mr
Elferink
A Bill for an Act to amend the Misuse of Drugs Act
NORTHERN TERRITORY OF AUSTRALIA
MISUSE OF DRUGS AMENDMENT ACT 2013
____________________
Act No. [ ] of 2013
____________________
Table of provisions
46 Transitional
provision for Misuse of Drugs Amendment Act 2013
NORTHERN
TERRITORY OF AUSTRALIA
____________________
Act No. [ ] of 2013
____________________
An Act to amend the Misuse of Drugs Act
[Assented to [ ] 2013]
[Second reading [ ] 2013]
The Legislative Assembly of the Northern Territory enacts as follows:
This Act may be cited as the Misuse of Drugs Amendment Act 2013.
This Act commences on the day fixed by the Administrator by Gazette notice.
This Act amends the Misuse of Drugs Act.
(1) Section 5(2)(a)(iv)
omit
to a person
(2) Section 5(3)
omit, insert
(3) In a prosecution for an offence against subsection (2), a statement in the complaint or information that the place at which the alleged supply occurred, or was to occur, was at the relevant time an indigenous community, is evidence of the matters stated.
(1) Section 37(1), definition aggravating circumstance, paragraph (c)
omit
pool.
insert
pool; or
(2) Section 37(1), definition aggravating circumstance, after paragraph (c)
insert
(d) an offence against section 5 that was committed in an indigenous community.
(3) Section 37(1), definition aggravating circumstance, paragraphs (a) and (aa), at the end
insert
or
After section 43(2)(a)
insert
(aa) amend Schedules 1 and 2 to this Act by omitting a substance or plant (including part of a plant) from Schedule 2 and inserting that substance or plant in Schedule 1 and specifying the relevant traffickable quantity and commercial quantity in respect of that substance or plant;
Before Schedule 1
insert
46 Transitional provision for Misuse of Drugs Amendment Act 2013
(1) This Act, as amended by the Misuse of Drugs Amendment Act 2013, applies only in relation to offences committed after the commencement of this section (commencement).
(2) This Act, as in force before commencement, continues to apply in relation to offences committed before commencement.
(3) For this section:
(a) an offence is taken to have been committed after commencement only if all of the conduct constituting the offence occurred after commencement; and
(b) any other offence is taken to have been committed before commencement.
Schedule 2
repeal, insert
section 3
COLUMN 1
Dangerous drug or prohibited plant
|
COLUMN 2
Traffickable quantity
|
COLUMN 3
Commercial quantity
|
Acetorphine
|
2.00 g
|
100.00 g
|
Acetyl-a-methylfentanyl
|
0.005 g
|
0.25 g
|
Acetyldihydrocodeine, except when compounded with
one or more other medicaments:
|
2.00 g |
100.00 g |
(a) in divided preparations containing not more than
100 mg of acetyldihyd-rocodeine per dosage unit; or
|
|
|
(b) in undivided preparations with a concentration
of not more than 2.5% of acetyldihydrocodeine
|
|
|
Acetylmethadol
|
2.00 g
|
100.00 g
|
Acetylmorphines
|
2.00 g
|
100.00 g
|
Adamantoylindoles
|
50.0 g
|
500.00 g
|
Adamantylamidoindazoles
|
50.0 g
|
500.00 g
|
Adamantylamidoindoles
|
50.0 g
|
500.00 g
|
Alfentanil
|
0.005 g
|
0.25 g
|
Alkoxyamphetamines and bromo-substituted
alkoxyamphetamines, except where separately specified in this
Schedule
|
0.50 g |
25.00 g |
Alkoxyphenethylamines and alkyl-substituted
alkoxyphene-thylamines, except where separately specified in this
Schedule
|
0.50 g |
25.00 g |
Alkythioamphetamines
|
0.50 g
|
25.00 g
|
Allylprodine
|
2.00 g
|
100.00 g
|
Alphacetylmethadol
|
10.00 g
|
500.00 g
|
Alphameprodine
|
0.20 g
|
10.00 g
|
Alphamethadol
|
0.20 g
|
10.00 g
|
Alphaprodine
|
25.00 g
|
1.25 kg
|
2-Amino-1-(2,5-dimethoxy-4-methyl) phenylpropane
(STP, DOM)
|
0.50 g |
10.00 g |
Amphetamine
|
2.00 g
|
100.00 g
|
Amylobarbitone
|
20.00 g
|
1.00 kg
|
Anileridine
|
25.00 g
|
1.25 kg
|
|
|
|
Benzethidine
|
10.00 g
|
500.00 g
|
Benzoylindoles
|
50.0 g
|
500.00 g
|
Benzylmorphine
|
5.00 g
|
250.00 g
|
Benzylpiperazine
|
2.00 g
|
100.00 g
|
Betacetylmethadol
|
5.00 g
|
250.00 g
|
Betameprodine
|
5.00 g
|
250.00 g
|
Betamethadol
|
5.00 g
|
250.00 g
|
Betaprodine
|
5.00 g
|
250.00 g
|
Bezitramide
|
5.00 g
|
250.00 g
|
Bromo-dimethoxyamphetamine
|
0.05 g
|
2.50 g
|
Bromo-dimethoxyphenethylamine
|
0.50 g
|
25.00 g
|
2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
(25B-NBOMe)
|
0.50 g |
25.00 g |
Bromo-methoxyamphetamine
|
0.50 g
|
25.00 g
|
Bufotenine
|
2.00 g
|
100.00 g
|
Butobarbitone
|
20.00 g
|
1.00 kg
|
Butorphanol
|
2.00 g
|
100.00 g
|
|
|
|
Cannabis oil
|
1.00 g
|
25.00 g
|
Cannabis plant
|
not less than 5 nor more than
19 plants
|
not less than 20 plants
|
Cannabis plant material (being any part of the
Cannabis plant, including the flowering or fruiting tops, leaves, stalks and
seeds
|
50.00 g |
500.00 g |
Cannabis resin
|
10.00 g
|
100.00 g
|
Cannabis seed
|
10.00 g
|
100.00 g
|
Cathinone
|
2.00 g
|
100.00 g
|
2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
(25C-NBOMe)
|
0.50 g |
25.00 g |
Clonitazene
|
5.00 g
|
250.00 g
|
Coca Leaf
|
250.00 g
|
5.00 kg
|
Codeine except when compounded with one or more
other medicaments:
(a) in divided preparations containing 30 mg or
less of codeine per dosage unit; or
(b) in undivided preparations containing 1% or less
of codeine
|
10.00 g |
500.00 g |
Codeine-N-oxide
|
10.00 g
|
500.00 g
|
Codoxime
|
10.00 g
|
500.00 g
|
Concentrate of Poppy Straw (the material arising
when poppy straw has entered into a process for concentration of its
alkaloids)
|
250.00 g |
5.00 kg |
4-Cyano-2-dimethylamino-4,
4-diphenylbutane (Methadone intermediate) |
2.00 g |
100.00 g |
4-Cyano-1-methyl-4-phenylpiperidine (Pethidine
intermediate A)
|
10.00 g |
500.00 g |
Cyclobarbitone
|
20.00 g
|
1.00 kg
|
1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole
*(RCS-8)
|
50.00 g |
500.00 g |
Cyclohexylphenols
|
50.0 g
|
500.00 g
|
Cyclopropanoylindoles
|
50.0 g
|
500.00 g
|
|
|
|
Desomorphine
|
2.00 g
|
100.00 g
|
Dextromoramide
|
2.00 g
|
100.00 g
|
Dextropropoxyphene, except when:
(a) in divided preparations containing 135 mg
or less of dextropropoxyphene per dosage unit; or
(b) in liquid preparations containing 2.5% or less
of dextropropoxyphene
|
27.00 g
|
1.35 kg
|
Diampromide
|
5.00 g
|
250.00 g
|
Diethylthiambutene
|
5.00 g
|
250.00 g
|
N,N-Diethyltryptamine (DET)
|
2.00 g
|
100.00 g
|
Difenoxin, except in preparations containing, per
dosage unit. 0.5 mg or less of difenoxin and a quantity of atropine sulphate
equivalent to at least 5% of the dose of difenoxin
|
2.00 g |
100.00 g |
Dihydrocodeine, except when compounded with one or
more other medicaments:
(a) in divided preparations containing not more than
100 mg of dihydrocodeine per dosage unit; or
(b) in undivided preparations with a concentration
of not more than 2.5% of dihydrocodeine
|
10.00 g |
500.00 g |
Dihydromorphine
|
10.00 g
|
500.00 g
|
Dimenoxadol
|
10.00 g
|
500.00 g
|
Dimepheptanol
|
10.00 g
|
500.00 g
|
Dimethoxyamphetamine
|
0.50 g
|
25.00 g
|
Dimethoxyethoxyamphetamine
|
0.50 g
|
25.00 g
|
Dimethoxyethylamphetamine
|
0.50 g
|
25.00 g
|
Dimethoxymethamphetamine
|
0.50 g
|
25.00 g
|
Dimethoxymethylenedioxyamphetamine
|
0.50 g
|
25.00 g
|
Dimethoxyphenethylamine
|
0.50 g
|
25.00 g
|
3-(2-Dimethylaminoethyl)-4-hydroxyindole (Psilocine,
Psilotsin)
|
0.10 g |
5.00 g |
3-(1,2-Dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo
(b,d)pyran (DMHP)
|
2.00 g |
100.00 g |
Dimethylthiambutene
|
20.00 g
|
1.00 kg
|
N,N,-Dimethyltryptamine (DMT)
|
2.00 g
|
100.00 g
|
Dioxaphetyl Butyrate
|
2.00 g
|
100.00 g
|
Diphenoxylate, except in preparations containing,
per dosage unit, 2.5 mg or less of diphenoxylate and a quantity of atropine
sulphate equivalent to at least 1% of the dose of diphenoxylate
|
2.00 g |
100.00 g |
Dipipanone
|
10.00 g
|
500.00 g
|
Drotebanol
|
2.00 g
|
100.00 g
|
|
|
|
Ecgonine
|
10.00 g
|
1.00 kg
|
Ethylamphetamine
|
2.00 g
|
100.00 g
|
4,5-Ethylenedioxy-3-methoxyamphetamine
|
0.50 g |
25.00 g |
Ethylmethylthiambutene
|
10.00 g
|
500.00 g
|
Ethylmorphine, except when compounded with one or
more other medicaments:
(a) in divided preparations containing not more than
100 mg of ethylmorphine per dosage unit; or
(b) in undivided preparations with a concentration
of not more than 2.5% of ethylmorphine
|
2.00 g |
100.00 g |
Eticyclidine (PCE)
|
2.00 g
|
100.00 g
|
Etonitazene
|
5.00 g
|
250.00 g
|
Etorphine
|
5.00 g
|
250.00 g
|
Etoxeridine
|
5.00 g
|
250.00 g
|
|
|
|
Fenetylline
|
2.00 g
|
100.00 g
|
Fentanyl
|
0.005 g
|
0.25 g
|
Fluorofentanyl
|
0.005 g
|
0.25 g
|
(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)
methanone *(XLR11)
|
50.0 g |
500.00 g |
1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole
*(AM-694)
|
50.00 g |
500.00 g |
1-(5-Fluoropentyl)-3-(1-naphthoyl)indole
*(AM-2201)
|
50.00 g |
500.00 g |
Furethidine
|
1.00 g
|
50.00 g
|
|
|
|
Harmaline
|
2.00 g
|
100.00 g
|
Harmine
|
2.00 g
|
100.00 g
|
3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo(b,d)pyran
(Parahexyl)
|
2.00 g |
100.00 g |
1-Hexyl-3-(1-naphthoyl)indole *(JWH-019)
|
50.00 g |
500.00 g |
Hydrocodone
|
2.00 g
|
100.00 g
|
Hydromorphinol
|
2.00 g
|
100.00 g
|
Hydromorphone
|
2.00 g
|
100.00 g
|
2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol
*(Cannabicyclohexanol or CP 47,497 C8 homologue)
|
50.00 g |
500.00 g |
2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol
*(CP 47,497)
|
50.00 g |
500.00 g |
Hydroxyfentanyl
|
0.005 g
|
0.25 g
|
9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6A,7,10,10A-tetrahydrobenzo[c]chromen-1-ol
*(HU-210) |
50.00 g |
500.00 g |
Hydroxymethylfentanyl
|
0.005 g
|
0.25 g
|
Hydroxypethidine
|
5.00 g
|
250.00 g
|
4-Hydroxybutanoic acid
|
2.00 g
|
100.00 g
|
|
|
|
2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
(25I-NBOMe)
|
0.50 g |
25.00 g |
Isomethadone
|
2.00 g
|
100.00 g
|
|
|
|
Ketobemidone
|
2.00 g
|
100.00 g
|
Ketamine
|
0.002 g
|
0.10 g
|
Khat leaf
|
250.00 g
|
5.00 kg
|
|
|
|
Levomethorphan
|
2.00 g
|
100.00 g
|
Levomoramide
|
2.00 g
|
100.00 g
|
Levophenacylmorphan
|
2.00 g
|
100.00 g
|
Levorphanol
|
1.00 g
|
50.00 g
|
|
|
|
Mecloqualone
|
60.00 g
|
3.00 kg
|
Metazocine
|
7.00 g
|
350.00 g
|
Methadone
|
2.00 g
|
100.00 g
|
Methaqualone
|
50.00 g
|
2.50 kg
|
Methcathinone
|
2.00 g
|
100.00 g
|
Methoxyethylenedioxyamphetamine
|
0.50 g
|
25.00 g
|
Methoxyethylenedioxyphenylethylamine
|
0.50 g
|
25.00 g
|
Methoxyamphetamine
|
0.50 g
|
25.00 g
|
Methoxymethylenedioxyamphetamine (MMDA)
|
0.50 g |
25.00 g |
Methoxymethylenedioxyphenethylamine
|
0.50 g
|
25.00 g
|
4-Methoxyphenyl(1butyl-1h-indol-3-yl)-methanone *(RCS-4
(C4))
|
50.00 g |
500.00 g |
2-(4-Methoxyphenyl)-1-(1-pentyl-1h-indol-3-yl)-ethanone
*(JWH-201)
|
50.0 g |
500.00 g |
2-(2-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone
*(JWH-250)
|
50.00 g |
500.00 g |
2-(3-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone
*(JWH-302)
|
50.0 g |
500.00 g |
Methoxyphenylethylamine
|
0.50 g
|
25.00 g
|
Methylenedioxyamphetamine (MDA);
|
0.50 g
|
25.00 g
|
Methylenedioxyethylamphetamine (MDEA)
|
0.50 g |
25.00 g |
2-Methyl-3-morpholino-1,1-diphenylpropane Carboxylic
Acid (Moramide intermediate)
|
8.00 g |
400.00 g |
1-Methyl-4-phenylpiperidine-4-carboxylic acid
(Pethidine intermediate C)
|
10.00 g |
500.00 g |
1-Methyl-4-phenyl-4-propionoxypiperidine
(MPPP)
|
2.00 g |
100.00 g |
Methyldesorphine
|
2.00 g
|
100.00 g
|
Methyldihydromorphine
|
2.00 g
|
100.00 g
|
Methylenedioxymethamphetamine (MDMA)
|
0.50 g |
25.00 g |
Methylfentanyl
|
0.005 g
|
0.25 g
|
Methylphenidate
|
2.00 g
|
100.00 g
|
Methylthiofentanyl
|
0.005 g
|
0.25 g
|
Metopon
|
2.00 g
|
100.00 g
|
Morpheridine
|
2.00 g
|
100.00 g
|
Morphine
|
2.00 g
|
100.00 g
|
Morphine Methobromide
|
2.00 g
|
100.00 g
|
Morphine-N-oxide
|
2.00 g
|
100.00 g
|
(1-(2-Morpholin-4-ylethyl)indol-3-yl)-naphthalen-1-ylmethanone
*(JWH-200)
|
50.00 g |
500.00 g |
Muscimol
|
2.00 g
|
100.00 g
|
Myrophine
|
20.00 g
|
1.00 kg
|
|
|
|
N-adamantyl-1-fluoropentylindole-3-Carboxamide
*(STS-135)
|
50.0 g |
500.00 g |
N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide
*(AKB48)
|
50.0 g |
500.00 g |
1-[(N-methylpiperidin-2-yl)methyl]-3-(adamant-1-oyl)
indole *(AM-1248)
|
50.0 g |
500.00 g |
Nabilone
|
0.40 g
|
20.00 g
|
Naphthalen-1-yl-(1-butylindol-3-yl)methanone
*(JWH-073) |
50.00 g |
500.00 g |
Naphthoylindoles
|
50.0 g
|
500.00 g
|
Naphthoylpyrroles
|
50.0 g
|
500.00 g
|
Naphthylmethylindenes
|
50.0 g
|
500.00 g
|
Naphthylmethylindoles
|
50.0 g
|
500.00 g
|
Nicocodine, except when compounded with one or more
other medicaments:
(a) in divided preparations containing not more than
100 mg of nicocodine per dosage unit; or
(b) in undivided preparations with a concentration
of not more than 2.5% of nicocodine
|
2.00 g |
100.00 g |
Nicodicodine, except when compounded with one or
more other medicaments:
(a) in divided preparations containing not more than
100 mg of nicodicodine per dosage unit; or
(b) in undivided preparations with a concentration
of not more than 2.5% of nicodicodine
|
2.00 g |
100.00 g |
Nicomorphine
|
2.00 g
|
100.00 g
|
Noracylmethadol
|
2.00 g
|
100.00 g
|
Norcodeine, except when compounded with one or more
other medicaments:
(a) in divided preparations containing not more than
100 mg of norcodeine per dosage unit; or
(b) in undivided preparations with a concentration
of not more than 2.5% of norcodeine
|
2.00 g |
100.00 g |
Norlevorphanol
|
2.00 g
|
100.00 g
|
Normethadone
|
5.00 g
|
250.00 g
|
Normorphine
|
20.00 g
|
1.00 kg
|
Norpipanone
|
10.00 g
|
500.00 g
|
|
|
|
Opium in any form, except the alkaloids noscapine
and papaverine
|
20.00 g |
100.00 g |
Oxycodone
|
5.00 g
|
250.00 g
|
Oxymorphone
|
2.00 g
|
100.00 g
|
|
|
|
Parahexyl
|
–
|
–
|
Pentazocine
|
20.00 g
|
1.00 kg
|
Pentobarbitone
|
20.00 g
|
1.00 kg
|
1-Pentyl-3-(4-chloro-1-naphthoyl)indole
*(JWH-398)
|
50.00 g |
500.00 g |
1-Pentyl-3-(2-chlorophenylacetyl)indole *(JWH-203)
|
50.0 g |
500.00 g |
1-Pentyl-3-(4-ethyl-1-naphthoyl)indole *(JWH-210)
|
50.0 g |
500.00 g |
1-Pentyl-1h-indol-3-yl-(1-naphthoyl)menthane
*(JWH-175) |
50.00 g |
500.00 g |
1-Pentyl-3-[(4-methoxy)-benzoyl]indole
*(RCS-4)
|
50.00 g |
500.00 g |
1-Pentyl-3-(4-methoxynaphthoyl)indole
*(JWH-081)
|
50.00 g |
500.00 g |
1-Pentyl-3-(4-methyl-1-naphthoyl)indole
*(JWH-122)
|
50.00 g |
500.00 g |
1-Pentyl-3-(1-naphthoyl)indole *(JWH-018)
|
50.00 g |
500.00 g |
(1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone
*(UR144)
|
50.0 g |
500.00 g |
Pethidine
|
10.00 g
|
500.00 g
|
Phenadoxone
|
10.00 g
|
500.00 g
|
Phenampromide
|
10.00 g
|
500.00 g
|
Phenazocine
|
1.00 g
|
50.00 g
|
Phendimetrazine
|
5.00 g
|
250.00 g
|
Phenmetrazine
|
5.00 g
|
250.00 g
|
Phenomorphan
|
5.00 g
|
250.00 g
|
Phenoperidine
|
1.00 g
|
50.00 g
|
Phenylacetylindoles
|
50.0 g
|
500.00 g
|
1-Phenylethyl-4-phenyl-4-acetoxypiperidine
(PEPAP)
|
2.00 g |
100.00 g |
4-Phenylpiperidine-4-carboxylic Acid Ethyl Ester
(Pethidine intermediate B)
|
10.00 g |
500.00 g |
Pholcodine, except when compounded with one or more
other medicaments:
(a) in divided preparations containing not more than
100 mg of pholcodine per dosage unit; or
(b) in undivided preparations with a concentration
of not more than 2.5% of pholcodine
|
5.00 g |
250.00 g |
Piminodine
|
10.00 g
|
500.00 g
|
Piritramide
|
1.00 g
|
50.00 g
|
Pravadoline *(WIN 48098)
|
50.00 g
|
500.00 g
|
Proheptazine
|
1.00 g
|
50.00 g
|
Prohibited plant, other than elsewhere described in
this Schedule
|
not less than 5 nor more than
19 plants
|
not less than 20 plants
|
Properidine
|
25.00 g
|
1.25 kg
|
Propiram
|
10.00 g
|
500.00 g
|
1-Propyl-2-methyl-3-(1-naphthoyl)indole *(JWH-015)
|
50.0 g |
500.00 g |
Psilocybin and its derivatives
|
0.10 g
|
5.00 g
|
|
|
|
Quinalbarbitone
|
20.00 g
|
1.00 kg
|
|
|
|
Racemethorphan
|
2.00 g
|
100.00 g
|
Racemoramide
|
2.00 g
|
100.00 g
|
Racemorphan
|
2.00 g
|
100.00 g
|
Rolicyclidine (PHP, PCPY)
|
2.00 g
|
100.00 g
|
|
|
|
Salvia Divinorum, including extracts and other
substances structurally derived from Salvia Divinorum
|
7.50 g |
375.00 g |
Secbutobarbitone
|
20.00 g
|
1.00 kg
|
Sufentanil
|
0.005 g
|
0.25 g
|
|
|
|
Tenocyclidine (TCP)
|
2.00 g
|
100.00 g
|
Tetrahydrocannabinols and their alkyl homologues
except:
(a) when separately specified in this
Schedule;
(b) in hemp seed oil, containing 50 mg/kg or
less of tetrahydrocannabinols, when labelled "Not for internal use" or "Not to
be taken"; or
(c) in products for purposes other than internal
human use containing 50 mg/kg or less of
tetrahydrocannabinols.
|
|
|
Tetramethoxyamphetamine
|
0.50 g
|
25.00 g
|
Thebacon
|
2.00 g
|
100.00 g
|
Thebaine
|
2.00 g
|
100.00 g
|
Thiofentanyl
|
0.005 g
|
0.25 g
|
Tilidine
|
20.00 g
|
1.00 kg
|
Trifluoromethylphenylpiperazine and other piperazine
derivatives
|
2.00 g |
100.00 g |
Trimeperidine
|
10.00 g
|
500.00 g
|
Trimethoxyamphetamine
|
0.50 g
|
25.00 g
|
Trimethoxyphenethylamine (mescaline) and other
substances structurally derived from methoxy-phenylethylamine,
except:
(a) methoxyphenamine; or
(b) where separately specified in this
Schedule
|
7.50 g |
375.00 g |
Trimethoxyphenyl-aminobutane
|
0.50 g
|
25.00 g
|
|
|
|
Anabolic
Steroids:
Danazol Dromostanolone propionate Ethylestrenol Fluoxymesterone Methandriol Methyltestosterone Nandrolone decanoate Nandrolone phenpropionate |
10.00 g 12.00 g 10.00 g 12.00 g 32.00 g 48.00 g 6.00 g 8.00 g |
500.00 g 600.00 g 500.00 g 600.00 g 1.60 kg 2.40 kg 300.00 g 400.00 g |
Oxandrolone
Oxymetholone Stanozolol Testolactone Testosterone Testosterone cypionate Testosterone enanthate Testosterone propionate except anabolic steroids in products packaged for ovulation control or in quantities which can lawfully be prescribed in accordance with Schedule 4 of the Poisons and Dangerous Drugs Act |
12.00 g
300.00 g 7.20 g 1.20 kg 2.40 g 32.00 g 32.00 g 12.00 g |
600.00 g
15.00 kg 360.00 g 6.00 kg 120.00 g 1.60 kg 1.60 kg 600.00 g |
This Act expires on the day after it commences.
[Index] [Search] [Download] [Related Items] [Help]